A Study to Evaluate the Safety and Efficacy of AT20-KLH Therapeutic Immunization in Clinically Asymptomatic HIV-1 Infected Patients Receiving HAART Therapy
Latest Information Update: 06 Jan 2016
At a glance
- Drugs AT20 KLH (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Medestea
Most Recent Events
- 06 Jan 2016 New trial record